L47-anti Dyslipidymic Agents Flashcards
What are anti dyslipidemic agents
Diverse group of drugs that reduce the level of lipids and lipoproteins
Types of anti-dyslipidemic agents
Anti-hypercholesterolemia agents: Statins,ezetimibe Anti-hypertriglyceridemia agents: Fibrates,omega 3 fatty acids Mixed:niacin
What do statins inhibit
HMG COA reductase
they inhibit cholesterol synthesis as well as intermediate compounds involved in differentiation proliferation and mobilization
How to statins inhibit cholesterol synthesis
In the liver by reversible competitive inhibition of the rate limiting step when this occurs deliver senses that cholesterol is inhibited so it up regulates LDL receptors that will uptake the circulating cholesterol thus reducing its blood level
What is the purpose of statins inhibiting intermediate compounds
They are involved in inflammatory reactions especially those link to cholesterol accumulation
Involved in expression of proteins linked to synthesis and clearance of verified lipo proteins
How are statins classified
According to lipid solubility into hydrophilic lipophilic mixed According to duration of action According to potency
How are the hydrophilic agents eliminated
By the kidney and they have minimal drug interactions
Describe lipophilic agents
Metabolized by the liver and have many drug interactions
Cause dose dependent elevation in hepatic enzymes that requires regular check up
more liable to induce different degrees of myopathy which can be diagnosed by CK levels by an increase to 3.5 fold upwards
How can the duration of action affect dose of statins
Some have a long half-life thus they are taken once daily any time while others are short acting so they are given twice daily one at night at the peak time of endogenous cholesterol synthesis
Why are statins major anti cholesterolemic agents used in treatment of dyslipidemia
Statins can variably modulate lipid profile by a significant dec mainly in total cholesterol and LDL-C
Can induce some reduction in TG and an elevation in HDL-C
Drug of choice in hypercholestrolemia in diabetics
Statins
Drugs never used in pregnancy
Statins
Fibrates
What does ezetimibe do
Inhibit selective cholesterol transporter:
NPC1L1
Inhibits exogenous cholesterol intake which stimulates liver to upregulate its LDL-R
When is ezetimibe given
Given as monotherapy in mild cases of hypercholestrolemia but its given more as adjuvant to statins in resistant cases of hypercholestrolemia since it has a safe profile
PPAR-a agonists
Fibrates